Lee Jung-Woo, Han Jae-Bok, Kim Sung-Su, Seong Shin
Department of East-West Medicine, Graduate School, Kyung Hee University, South Korea ; Soram Korean Medicine Hospital, Seoul, South Korea.
Soram Korean Medicine Hospital, Seoul, South Korea.
Case Rep Oncol. 2014 May 28;7(2):357-61. doi: 10.1159/000363284. eCollection 2014 May.
According to the 2008 World Cancer Report by the World Health Organization (WHO), colorectal cancer is one of the leading cancers worldwide. This case study evaluates the effectiveness of Korean medicine treatment, including herbal pharmacopuncture (HP), as a complementary treatment during FOLFIRI chemotherapy. A 73-year-old male who was diagnosed with metastatic colorectal cancer (mCRC) in September 2012 was treated concurrently with HP and FOLFIRI chemotherapy for 4 months. The effectiveness of the combined therapy was evaluated by CT. Furthermore, quality of life was assessed using a visual analogue scale. The tumor mass sizes of lung and lymph node metastases decreased, and the side effects caused by chemotherapy were mitigated. Based on these results, this case report suggests that Korean medicine treatment including HP therapy could be a complementary therapy for mCRC.
根据世界卫生组织（WHO）2008年的《世界癌症报告》，结直肠癌是全球主要癌症之一。本案例研究评估了韩医学治疗（包括草药针剂疗法）作为FOLFIRI化疗期间辅助治疗的有效性。一名于2012年9月被诊断为转移性结直肠癌（mCRC）的73岁男性，同时接受了草药针剂疗法和FOLFIRI化疗，为期4个月。通过CT评估联合治疗的有效性。此外，使用视觉模拟量表评估生活质量。肺和淋巴结转移的肿瘤肿块大小减小，化疗引起的副作用得到缓解。基于这些结果，本病例报告表明包括草药针剂疗法在内的韩医学治疗可能是mCRC的辅助治疗方法。
